Gynecologic Cancer study: Ascites Collection vs Fluid Collection
Official title Study Looking at Biomarkers in Ovarian Cancer
ClinicalTrials.gov ID: NCT03419689
What this study is testing
- What it's testing
- The study aims to identify biomarkers in gynecologic cancer that could help doctors make treatment decisions.
- Who it's for
- People who have been diagnosed with a gynecologic cancer such as ovarian cancer.
- What's involved
- Participants will provide blood, tumor tissue, ascites fluid, or other samples, and no new medication is given.
- Time commitment
- Samples are collected during one or more clinic visits; the overall study length is not specified.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older, women only
You may be able to join if
- Histological diagnosis of stage III or IV high grade serous ovarian, tubal or primary peritoneal cancer.
- Must be 18 years of age or older.
- Eastern Cooperative Oncology Group (ECOG) Performance Status 0-1.
- Have a life expectancy greater than or equal to 6 months.
- Able to provide adequate informed consent.
You likely can't join if
- Must not have early stage (I and II) high grade serous, tubal or primary peritoneal cancer.
- Must not have other tumour histology other than high grade serous.
- Must not have contraindication to tumour biopsy and/or blood sampling.
See the full eligibility criteria
- Histological diagnosis of stage III or IV high grade serous ovarian, tubal or primary peritoneal cancer.
- Must be 18 years of age or older.
- Eastern Cooperative Oncology Group (ECOG) Performance Status 0-1.
- Have a life expectancy greater than or equal to 6 months.
- Able to provide adequate informed consent.
- Willing to undergo blood or fluid collection and tumour biopsy
- Patients enrolled at the time of surgery must agree to have part of their tumour used for the purpose of the study.
- Archival tissue must be available for patients that are enrolled at the time of progression.
- Must not have early stage (I and II) high grade serous, tubal or primary peritoneal cancer.
- Must not have other tumour histology other than high grade serous.
- Must not have contraindication to tumour biopsy and/or blood sampling.
The study team makes the final eligibility decision.
Where it is enrolling
- Barrie, Ontario, Canada
- Kingston, Ontario, Canada
- London, Ontario, Canada
- Ottawa, Ontario, Canada
- Toronto, Ontario, Canada
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Barrie, Ontario, Canada; Kingston, Ontario, Canada; London, Ontario, Canada; Ottawa, Ontario, Canada; Toronto, Ontario, Canada. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.